Regulation of iNOS expression and glutathione levels in rat liver by oxygen tension  by Miralles, Cristina et al.
Regulation of iNOS expression and glutathione levels in rat liver by
oxygen tension
Cristina Mirallesa, Xavier Busquetsa, Carmen Santosa, Bernat Togoresa, Sabah Hussainb,
Irfan Rahmanc, William MacNeec, Alvar G.N. Agust|¤a;*
aUnidad de Investigacio¤n and the Servei de Pneumologia, Hospital Universitari Son Dureta, Palma de Mallorca, Spain
bDivision of Pulmonary and Critical Care Medicine, McGill University, Montreal, Que., Canada
cELEGI and Colt Laboratories, Respiratory Medicine Unit, University of Edinburgh, Edinburgh, UK
Received 25 May 2000
Edited by Barry Halliwell
Abstract Molecular oxygen (O2) regulates the expression of a
variety of genes. We hypothesized that O2 tension may regulate
iNOS expression in rat liver through the production of reactive
oxygen species (ROS) and the reduction of intracellular
glutathione (GSH) levels. To investigate this hypothesis, we
determined the effects of hyperoxia upon iNOS induction (both
at the protein and mRNA level) and the intracellular concentra-
tion of GSH in an isolated in vitro perfused rat liver preparation.
To study the potential involvement of ROS in the intracellular
signaling pathway linking changes in oxygen tension to gene
expression, we repeated these determinations in the presence of
the thiol antioxidant N-acetyl-L-cysteine (NAC). We found that
95% O2 tension caused a significant induction of the iNOS
protein and mRNA levels paralleled by a significant fall in
intracellular GSH concentration. The addition of NAC (1 mM)
to the perfusate during hyperoxia blocked the induction of iNOS
and restored GSH levels. These results indicate that molecular
O2 regulates the expression of iNOS in rat liver at the
transcriptional level, most likely through the production of
ROS and the reduction of intracellular GSH levels. ß 2000
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Nitric oxide (NO) is an important regulatory molecule in
many cell signaling pathways [1]. NO is synthesized by the
action of the NO synthases (NOS). To date, three main iso-
forms of NOS have been identi¢ed: type I NOS (also named
brain constitutive or bNOS), type II NOS (inducible or iNOS)
and type III NOS (endothelial constitutive or ecNOS) [1]. In
the liver, ecNOS is expressed constitutively and is highly
abundant both at the mRNA [2] and at the protein level [3].
In contrast, the iNOS gene is not expressed constitutively
[2,3], but it is upregulated by several pro-in£ammatory cyto-
kines [4,5], oxidative stress [6,7] as well as by ischemia/reper-
fusion [8,9]. This latter condition is characterized by changes
in tissue oxygen (O2) tension, the excessive production of re-
active oxygen species (ROS) [10^12] and changes in intracel-
lular reduced glutathione (GSH) levels [13,14].
GSH is a ubiquitous cellular non-protein sulphydryl in-
volved in the detoxi¢cation of peroxides, free radicals and
electrophilic compounds [15]. It therefore plays an important
role in the maintenance of the intracellular redox balance and
the regulation of several redox sensitive transcription factors,
such as nuclear factor-UB and AP-1 [16]. In endothelial cells,
these transcription factors regulate the expression of bNOS,
ecNOS and iNOS [5,17^20].
We hypothesized that, in rat liver, O2 tension may regulate
iNOS expression through the production of oxidative stress
and the reduction of intracellular GSH levels. To investigate
this hypothesis, we determined the e¡ects of hyperoxia upon
iNOS induction (both at the protein and mRNA level) and
the intracellular concentration of GSH and its oxidized form
(GSSG) in an isolated in vitro perfused rat liver preparation.
To study the potential involvement of ROS in the intracellular
signaling pathway linking changes in oxygen tension to gene
expression, we repeated these determinations in the presence
of the thiol antioxidant N-acetyl-L-cysteine (NAC).
2. Materials and methods
2.1. Animals
Male Sprague^Dawley rats (IFFA-Credo, Barcelona, Spain) (200^
300 g) were used in all the experiments. The animals were housed
under controlled environmental conditions (22‡C, 70% humidity and
12 h light/dark cycle) with free access to food and water. This study
was approved by the Research and Ethical Review Board of the
Hospital Universitari Son Dureta.
2.2. Isolated rat liver preparation
The isolated rat liver procedures were performed using previously
described methodology [21]. Brie£y, during intraperitoneal thiobarbi-
tal anesthesia (B. Braun Medical SA, Jaen, Spain), rats were subjected
to a midline laparotomy. The portal vein and the inferior vena cava
were catheterized. Livers were immediately transferred to and per-
fused in a temperature-controlled (37‡C) organ bath (Radnoti, Mon-
rovia, CA, USA) through the portal vein with Krebs^Henseleit bu¡er
(120 mM NaCl, 4.7 mM KCl, 14.5 mM MgSO4, 1.6 mM CaCl2, 25
mM NaHCO3, 11.2 mM glucose; pH 7.4 at 37‡C), using a constant
£ow peristaltic pump (Easy-load, Master£ex, Cole-Parmer Instrument
Co., Vernon Hills, USA). Flow was kept constant throughout the
experiment. Typically, £ow values (measured by timed collection of
the e¥uent £ow) ranged between 18 and 25 ml/min. Perfusion pres-
sure was continuously monitored at the entrance of the liver using a
pressure transducer (Harvard Apparatus, South Natick, MA, USA).
Pressure values ranging from 8 to 13 mm Hg were maintained
through the experiment in all animals. The PO2 in the perfusate
was kept constant by bubbling vigorously the Krebs^Henseleit reser-
voir with 95% O2, 5% CO2. The actual PO2 delivered to the liver was
monitored by a polarographic O2 electrode (Instech, Radnoti, Mon-
rovia, CA, USA). The PO2 electrode was calibrated in situ, before
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perfusing the liver, by equilibrating the Krebs^Henseleit bu¡er with
calibrated gas mixtures. Typical in£ow PO2 values oscillate around
500^600 mm Hg. At the end of the experiment, after 4 h of perfusion
in the organ bath, liver biopsies were taken and frozen immediately in
liquid nitrogen.
2.3. Experimental protocol
We studied four experimental groups (n = 6, each). Livers were per-
fused under normoxic (21% O2) or hyperoxic (95% O2) conditions,
with or without NAC (1 mM) dissolved in the perfusate. Hyperoxic
livers were perfused in the organ bath, following the methodology
outlined above. By contrast, given that the purpose of the normoxic
group was to obtain a baseline value of the di¡erent variables studied,
normoxic livers were perfused in situ (not in the organ bath) during a
brief period of time (typically less than 15 s), until complete blanching
of the liver, when a biopsy was immediately taken and frozen in liquid
N2. Frozen liver samples were processed equally in the four groups.
2.4. Immunodetection of iNOS and K-tubulin
Frozen liver samples (300^400 mg) were homogenized (1:10 w/v) in
cold 40 mM Tris bu¡er pH 7.5 containing 1% Triton X-100, 1 mM
MgCl2, 5 mM NaCl, 1 mM EDTA and the protease inhibitors phe-
nylmethylsulphonyl £uoride (1 mM) and leupeptin (40 Wg/ml). Sam-
ples were centrifuged at 12 000Ug for 10 min at 4‡C. 100 Wl of the
resulting supernatant was mixed with an equal volume of loading
bu¡er (62.5 mM Tris, pH 6.8, 3% sodium dodecyl sulphate (SDS),
20% glycerol, 0.005% bromophenol blue), which was then boiled for
4 min. Proteins were determined by the method of Bradford [22]. 5^20
Wl of the resulting suspension was loaded in a 10% polyacrylamide gel
and submitted to electrophoresis (SDS^polyacrylamide gel electropho-
resis). Proteins were transferred to nitrocellulose membranes (immu-
noblot, Western blot) that were incubated in phosphate-bu¡ered sa-
line containing 4% non-fat dry milk (blocking solution) for 1 h at
room temperature with gentle rocking. Then, membranes were incu-
bated overnight at 4‡C in blocking solution containing the primary
antibody, anti-iNOS (NOS II) rabbit polyclonal antibody at 1:150
dilution (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA),
or anti-K-tubulin mouse monoclonal antibody (Sigma Chemical Co.,
St. Louis, MO, USA) at 1:2000 dilution. The speci¢city of the anti-
iNOS antibody was determined by Western blot analysis of a positive
control of puri¢ed iNOS from mouse macrophages (Transduction
Laboratories, San Diego, CA, USA). The secondary antibodies, a
horseradish peroxidase-linked sheep anti-rabbit IgG for iNOS and a
horseradish peroxidase-linked donkey anti-mouse IgG for K-tubulin
(Amersham International, Buckinghamshire, UK), were both incu-
bated at 1:1000 dilution in blocking solution at room temperature
for 2 h. Immunoreactivity was detected with a chemiluminescence
Western blot detection system (Pierce, Rockford, IL, USA). Films
were scanned and densitometric analysis of the immunoreactive bands
was performed with the aid of the SigmaGel gel analysis software
(Jandel Scienti¢c Corporation, San Rafael, CA, USA).
2.5. RNA extraction
Total RNA was extracted from frozen liver samples by use of a
single-step RNA isolation system (TRIzol reagent, Gibco BRL; Life
technologies, Grand Island, NY, USA), which is based on the method
of Chomczynski and Sacchi [23]. Brie£y, 300 mg of rat liver samples
was homogenized in 1 ml TRIzol reagent (Gibco BRL) during 30 s
using an Ultra-Turrax T25 homogenizer (IKA, Staufen, Germany)
and then incubated for 5 min at room temperature. 200 Wl of chloro-
form was added to homogenates, which were then vortexed for 30 s,
and incubated at room temperature for 5 min. Samples were centri-
fuged at 12 000Ug for 10 min at 4‡C. The aqueous phases were
separated and mixed with 500 Wl of 100% isopropyl alcohol. Mixtures
were incubated for 10 min at room temperature and centrifuged at
10 000Ug for 10 min at 4‡C. The RNA precipitates were washed twice
with 1 ml of 75% ethanol dissolved in diethyl pyrocarbonate-treated
water. RNA was quantitated spectrophotometrically by measuring the
absorbance at 260 nm.
2.6. Reverse transcription-polymerase chain reaction (RT-PCR)
iNOS and tubulin mRNA levels were assessed by RT-PCR using
the Access RT-PCR System (Promega, Madison, WI, USA) following
the procedure of the manufacturer. Brie£y, RNA (2 Wg) was mixed
with 10 Wl of AMV/T£ 5U reaction bu¡er, 1 Wl T£ DNA polymerase
(5 U/Wl), 1 Wl AMV reverse transcriptase (5 U/Wl), 1 Wl dNTP mix (10
mM each dNTP), 2 Wl MgSO4 25 mM and 50 pmol of each primer.
The ¢nal volume of RT-PCR reaction was 50 Wl. Each reaction mix-
ture was overlaid with 50 Wl of mineral oil. The RT-PCR was per-
formed with a DNA thermal Cycler (Hybaid Omnigene, UK). The
oligonucleotide primers for PCR of iNOS were as follows: iNOS
primer 1, 5P-CCACAATAGTACAATACTACTTGG-3P ; primer 2,
5P-ACGAGGTGTTCAGCGTGCTCCACG-3P. The PCR product
generated using these primers was a 397 bp fragment. The primers
for K-tubulin were as follows: primer 1, 5P-CTCCATCCTCAC-
CACCCACAC-3P ; primer 2, 5P-CAGGGTCACATTTCACCATCT-
3P. The PCR product generated using these primers was a 365 bp
fragment. The speci¢city of the primers was assessed by sequence
analyses using the basic local alignment search tool program
(BLASTN 1.4.10MP) [24] from the National Center for Biotechnol-
ogy Information and the GenBank nucleic acid sequence database.
The cycling program for iNOS was: reverse transcription 45 min at
48‡C in one ampli¢cation cycle; then denaturation for 1 min at 95‡C,
annealing for 1 min at 62‡C and extension for 2.5 min at 72‡C. The
cycling program for K-tubulin was: reverse transcription for 45 min at
48‡C in one ampli¢cation cycle; then denaturation 1 min at 94‡C,
annealing 1 min at 52‡C and extension for 1 min at 72‡C. After
completion of RT-PCR (25 cycles for iNOS and K-tubulin), 25 Wl
of the reaction volume was separated on 2% agarose gel electropho-
resis and stained with ethidium bromide. Films were scanned and
densitometric analysis of the £uorescent bands (integrated optical
Fig. 1. Representative Western blot showing the iNOS and K-tubu-
lin bands in three normoxic and three hyperoxic livers (A), as well
as the e¡ects of NAC (1 mM) during hyperoxia in three other livers
(B). C shows the mean ( þ S.E.M.) values of iNOS immunoreactivity
(IOD) in the three experimental groups (n = 6, each). **P6 0.01,
compared with normoxic values.
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density, IOD) was performed with the aid of the SigmaGel analysis
software (Jandel Scienti¢c Corporation, San Rafael, CA, USA). iNOS
mRNA levels were expressed as the ratio between iNOS and K-tubulin
band signal intensities.
2.7. GSH assay
Liver samples (100 mg) were homogenized in 2 ml of cold 0.6%
(w/v) 5-sulphsalicylic acid and 0.1% (v/v) Triton X-100 in potassium
phosphate bu¡er (5 mM)^EDTA (1 mM) as described previously [25].
The homogenate was then centrifuged at 4000Ug for 10 min at 4‡C.
The supernatant was used immediately in the soluble GSH assay by
the 5,5P-dithiobis-(2-nitrobenzoic acid)^GSSG reductase recycling
method described by Tietze [26]. To determine GSSG, supernatant
was treated with 2-vinylpyridine and triethanolamine as previously
described [27], and thereafter was used in the assay for GSH as de-
scribed above.
2.8. Statistical analysis
Data are presented as mean þ S.E.M. The statistical signi¢cance of
di¡erences between groups was assessed using the Mann^Whitney
test. A P value lower than 0.05 was considered signi¢cant.
3. Results
3.1. iNOS expression
In all experimental groups, the relative molecular mass
of iNOS (V130 kDa) detected by Western blot was in the
range described for this protein [28]. As shown in Fig. 1,
during normoxia, iNOS bands were barely detectable
(109.78 þ 48.07 IOD). In contrast, the immunoreactivity of
the iNOS band was strongly increased during hyperoxia
(566.93 þ 109.57 IOD, P6 0.005) (Fig. 1A,C). When NAC
was added to the perfusion bu¡er, hyperoxia did not upregu-
late iNOS immunoreactivity (Fig. 1B,C). NAC did not in£u-
ence iNOS immunoreactivity during normoxia (130.33 þ 16.82
vs. 141.00 þ 28.00 IOD, P = ns).
Fig. 2A,B shows the results of the ampli¢cation of speci¢c
cDNAs fragments for iNOS (395 bp) and K-tubulin (365 bp),
as a RNA loading control. During normoxia, the iNOS
cDNA product was very low (iNOS/K-tubulin: 12.13 þ 3.98
IOD) (Fig. 2A,B). Hyperoxia increased the iNOS message
very signi¢cantly (iNOS/K-tubulin: 133.26 þ 23.42 IOD,
P6 0.005) (Fig. 2A,B). The presence of NAC in the perfusion
bu¡er completely prevented the upregulation of iNOS mRNA
levels during hyperoxia (iNOS/K-tubulin: 53.83 þ 24.79 IOD,
P6 0.05) (Fig. 2A,B).
Fig. 2. A: RT-PCR analysis of iNOS and K-tubulin mRNA in all groups (n = 6, each); m (molecular weight marker) is an internal control that
ampli¢es a 323 bp fragment (Promega, Madison, WI, USA). B: Mean ( þ S.E.M.) values of iNOS/K-tubulin cDNA ratio in the three experi-
mental groups (n = 6, each). *P6 0.05; **P6 0.01, compared with normoxic values.
Fig. 3. E¡ect of normoxia and hyperoxia in the absence or presence
of NAC (1 mM) on GSH and GSSG levels in rat liver. Each histo-
gram represents the mean ( þ S.E.M.) of three experiments.
*P6 0.05; **P6 0.01; ***P6 0.001, compared with normoxic val-
ues.
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3.2. GSH levels
Compared to control normoxic livers (2.24 þ 0.19), hyper-
oxia exposure signi¢cantly decreased GSH (1.17 þ 0.15,
P6 0.001) and increased GSSG levels (hyperoxia:
0.52 þ 0.13 vs. controls: 0.19 þ 0.05) (Fig. 3). As a result, hy-
peroxia produced a 5-fold decrease in the GSH/GSSG ratio,
as compared to control normoxic values (11.8 þ 6.40 vs.
2.3 þ 1.9, P6 0.001). The presence of NAC during hyperoxia
prevented the fall of the GSH/GSSG ratio (11.1 þ 1.9, P = ns),
which was close to control normoxic values (3.1 þ 0.25,
P6 0.01 compared to controls) (GSSG: 0.28 þ 0.17, P = ns
compared to controls) (Fig. 3).
4. Discussion
This study shows that O2 tension modulates the expression
of the iNOS gene in rat liver. Given that parallel changes
occurred in GSH and GSH/GSSG levels, and that all these
e¡ects are prevented by NAC, our results suggest that ROS
are likely to be key factors in the signal transduction pathway
linking changes in O2 tension and iNOS expression in rat
liver.
The iNOS isoform is expressed in a variety of cell types and
tissues, including human and rat hepatocytes, by the action of
cytokines, or lipopolysacharide [29^33]. Whether or not mo-
lecular O2 regulates iNOS expression in the liver has not been
investigated before. Our results show that control livers (per-
fused in situ with 21% O2) express very low levels of iNOS
immunoreactivity and iNOS mRNA (Figs. 1 and 2). It is
normally assumed that iNOS is not constitutively expressed
in the liver [2,3]. Probably, the very low levels of iNOS ex-
pression detected in our normoxic samples can be explained
by the mechanical stress su¡ered by the organ during the
experimental procedure [34,35]. We observed that hyperoxia
strongly induced both the iNOS protein (Fig. 1) and iNOS
mRNA (Fig. 2). A similar induction of iNOS by hyperoxia
has been demonstrated in human lung [6] and, in a very recent
report, in rat liver by ischemia and reperfusion [9]. This latter
condition involves changes in tissue oxygenation. However, at
variance with our study, it also involves changes in blood £ow
and substrate delivery. Therefore, our study con¢rms and ex-
tends previous studies by showing that molecular oxygen by
itself can trigger the expression of iNOS in isolated, perfused
rat livers (Fig. 1), and that this induction appears to be regu-
lated at the transcriptional level (Fig. 2).
Molecular oxygen can regulate iNOS transcription through
several potential mechanisms. In this study, we investigated if
ROS (produced during hyperoxia [20]) were capable of mod-
ulating intracellular redox GSH levels and thus trigger signal-
ing pathways that link changes in O2 tension to gene expres-
sion [20]. During hyperoxia (and compared to normoxia), we
observed that GSH levels fell and GSSG concentration in-
creased, with a corresponding decrease in the GSH/GSSG
ratio (Fig. 3). These observations already suggest a role of
ROS in the hyperoxia-mediated induction of the iNOS gene.
However, to further investigate this possibility, we repeated
the same experiments discussed above in the presence of thiol
antioxidant NAC (1 mM). NAC is known to bu¡er cysteine/
GSH levels in the cell and to scavenge ROS, both in vitro and
in vivo [10,36]. Our results show that during hyperoxia, the
presence of NAC in the perfusate inhibited the upregulation
of the iNOS gene, both at the protein (Fig. 1) and mRNA
levels (Fig. 2), and reversed the GSH/GSSG ratio close to
normoxic values (Fig. 3). Our results are in coincidence with
other recent studies showing an increase of GSH levels by
NAC [39,40]. Therefore, our results suggest that ROS are
involved in the induction of the iNOS gene in rat liver. This
would be in keeping with previous reports in RAW264.7 cells
[37], rat glomeruli [38], endothelial cells [14], rat pleural mes-
othelial cells [7] and lung epithelial cells [13]. Nonetheless,
apart from a direct e¡ect of ROS upon gene expression [20],
other potential mechanisms by which changes in O2 tension
can theoretically modulate the expression of the iNOS gene
include the e¡ects of O2 on the expression of several pro-
in£ammatory cytokines, such as IL-1L and TNF-K [41,42].
By their own, these cytokines are potent inducers of iNOS
expression in many cell types and tissues, including human
and rat hepatocytes [29^33,43]. Therefore, the possibility of
a direct involvement of these pro-in£ammatory mediators in
the upregulation of iNOS gene in this model cannot be ruled
out. In any case, however, the decrease in GSH/GSSG ratio
caused by O2 and the fact that NAC fully prevented the in-
duction of the iNOS gene under these circumstances indicate
that, even if operative, these alternative mechanisms should
also be mediated by ROS.
In summary, the results of this study indicate that molec-
ular oxygen modulates the expression of the iNOS gene in rat
liver. Given that this e¡ect is paralleled by changes in GSH/
GSSG ratio and it is inhibited by the thiol antioxidant NAC,
we suggest that ROS are likely to be involved in the transcrip-
tional induction of the iNOS gene by molecular oxygen.
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